Search research articles
Contact Us
Filters
Showing results (111-120 of 141) with videos related to
Page
of 15
Sort By:
Surgical Endoscopy
|
February 9, 2026
Clinical practice of indocyanine green fluorescence imaging in robotic liver surgery - a global expert survey
Noa L E Aegerter, Christoph Kuemmerli, Adrian T Billeter, et al.
Hepatology Communications
|
December 24, 2021
Immunological Aspects of AXL/GAS-6 in the Context of Human Liver Regeneration
Gregor Ortmayr, Laura Brunnthaler, David Pereyra, et al.
Ebiomedicine
|
September 17, 2025
PNPLA3 polymorphism worsens chemotherapy associated liver injury and affects overall survival in colorectal cancer patients with liver metastasis undergoing hepatic resection
Benedikt Rumpf, Jonas Santol, Anna E Kern, et al.
Hepatology Communications
|
December 15, 2023
Intrahepatic neutrophil accumulation and extracellular trap formation are associated with posthepatectomy liver failure
Laura Brunnthaler, David Pereyra, Miriam Brenner, et al.
Hepatology (Baltimore, Md.)
|
October 20, 2020
Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery
Patrick Starlinger, David Pereyra, Hubert Hackl, et al.
Journal of Neuroendocrinology
|
February 13, 2025
Alternative lengthening of telomeres and Ki-67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumors
Hallbera Gudmundsdottir, Rondell P Graham, Patricia T Greipp, et al.
Journal of Hepatology
|
December 21, 2016
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
Philipp Schwabl, Eva Hambruch, Berit A Seeland, et al.
The Oncologist
|
December 14, 2024
Second-line therapies in advanced hepatocellular carcinoma following first-line atezolizumab and bevacizumab: multicenter single institution cohort experience
Paulina Marell, Ioannis Kournoutas, Jennifer Gile, et al.
Cell Reports
|
March 18, 2023
ILC3s restrict the dissemination of intestinal bacteria to safeguard liver regeneration after surgery
Manuel O Jakob, Daniel Spari, Daniel Sànchez Taltavull, et al.
Oncotarget
|
May 21, 2017
Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
Mirko Dengler, Katharina Staufer, Heidemarie Huber, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 141) with videos related to
Sort By:
Page
of 15
Surgical Endoscopy
|
February 9, 2026
Clinical practice of indocyanine green fluorescence imaging in robotic liver surgery - a global expert survey
Noa L E Aegerter, Christoph Kuemmerli, Adrian T Billeter, et al.
Hepatology Communications
|
December 24, 2021
Immunological Aspects of AXL/GAS-6 in the Context of Human Liver Regeneration
Gregor Ortmayr, Laura Brunnthaler, David Pereyra, et al.
Ebiomedicine
|
September 17, 2025
PNPLA3 polymorphism worsens chemotherapy associated liver injury and affects overall survival in colorectal cancer patients with liver metastasis undergoing hepatic resection
Benedikt Rumpf, Jonas Santol, Anna E Kern, et al.
Hepatology Communications
|
December 15, 2023
Intrahepatic neutrophil accumulation and extracellular trap formation are associated with posthepatectomy liver failure
Laura Brunnthaler, David Pereyra, Miriam Brenner, et al.
Hepatology (Baltimore, Md.)
|
October 20, 2020
Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery
Patrick Starlinger, David Pereyra, Hubert Hackl, et al.
Journal of Neuroendocrinology
|
February 13, 2025
Alternative lengthening of telomeres and Ki-67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumors
Hallbera Gudmundsdottir, Rondell P Graham, Patricia T Greipp, et al.
Journal of Hepatology
|
December 21, 2016
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
Philipp Schwabl, Eva Hambruch, Berit A Seeland, et al.
The Oncologist
|
December 14, 2024
Second-line therapies in advanced hepatocellular carcinoma following first-line atezolizumab and bevacizumab: multicenter single institution cohort experience
Paulina Marell, Ioannis Kournoutas, Jennifer Gile, et al.
Cell Reports
|
March 18, 2023
ILC3s restrict the dissemination of intestinal bacteria to safeguard liver regeneration after surgery
Manuel O Jakob, Daniel Spari, Daniel Sànchez Taltavull, et al.
Oncotarget
|
May 21, 2017
Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
Mirko Dengler, Katharina Staufer, Heidemarie Huber, et al.
Page
of 15